Summit X LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-7,328
| Closed | -$691K | – | 217 |
|
2023
Q2 | $691K | Buy |
7,328
+83
| +1% | +$7.83K | 0.17% | 122 |
|
2023
Q1 | $599K | Sell |
7,245
-315
| -4% | -$26.1K | 0.15% | 133 |
|
2022
Q4 | $719K | Buy |
7,560
+90
| +1% | +$8.56K | 0.21% | 102 |
|
2022
Q3 | $619K | Sell |
7,470
-90
| -1% | -$7.46K | 0.18% | 123 |
|
2022
Q2 | $721K | Sell |
7,560
-150
| -2% | -$14.3K | 0.21% | 103 |
|
2022
Q1 | $905K | Sell |
7,710
-3,235
| -30% | -$380K | 0.22% | 94 |
|
2021
Q4 | $1.42M | Buy |
10,945
+70
| +0.6% | +$9.05K | 0.33% | 70 |
|
2021
Q3 | $1.23M | Sell |
10,875
-15
| -0.1% | -$1.7K | 0.31% | 73 |
|
2021
Q2 | $1.13M | Sell |
10,890
-205
| -2% | -$21.2K | 0.28% | 86 |
|
2021
Q1 | $928K | Sell |
11,095
-300
| -3% | -$25.1K | 0.25% | 96 |
|
2020
Q4 | $1.04M | Sell |
11,395
-310
| -3% | -$28.2K | 0.31% | 79 |
|
2020
Q3 | $3.59K | Buy |
11,705
+3,395
| +41% | +$1.04K | 0.06% | 144 |
|
2020
Q2 | $574K | Buy |
8,310
+210
| +3% | +$14.5K | 0.21% | 108 |
|
2020
Q1 | $513K | Sell |
8,100
-495
| -6% | -$31.4K | 0.24% | 99 |
|
2019
Q4 | $665K | Sell |
8,595
-2,175
| -20% | -$168K | 0.25% | 104 |
|
2019
Q3 | $789K | Sell |
10,770
-30
| -0.3% | -$2.2K | 0.32% | 87 |
|
2019
Q2 | $662K | Buy |
10,800
+30
| +0.3% | +$1.84K | 0.27% | 97 |
|
2019
Q1 | $690K | Buy |
10,770
+495
| +5% | +$31.7K | 0.3% | 90 |
|
2018
Q4 | $525K | Buy |
10,275
+90
| +0.9% | +$4.6K | 0.3% | 94 |
|
2018
Q3 | $592K | Buy |
10,185
+90
| +0.9% | +$5.23K | 0.29% | 87 |
|
2018
Q2 | $488K | Sell |
10,095
-702
| -7% | -$33.9K | 0.27% | 99 |
|
2018
Q1 | $506K | Buy |
10,797
+192
| +2% | +$9K | 0.3% | 89 |
|
2017
Q4 | $405K | Buy |
10,605
+150
| +1% | +$5.73K | 0.26% | 119 |
|
2017
Q3 | $377K | Buy |
10,455
+60
| +0.6% | +$2.16K | 0.25% | 117 |
|
2017
Q2 | $411K | Buy |
+10,395
| New | +$411K | 0.29% | 105 |
|